Delivery Order SPE2DB22D3301-SPE2DB24FX3HM

Award Date 10/6/23
Potential Completion Date 10/10/23
Potential Value $2.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,114.21 Firm Fixed Price delivery order is for the supply of Colestipol HCL 1 GM Tablets in quantities of 120 tablets. The award has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,570.59 firm fixed-price delivery order is for the supply of Colestipol HCL 1 GM Tablets, with a completion date of May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC...
This federal contract award, valued at $1,614.93, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Colestid 1 GM Tablet 120S, a pharmaceutical product, with a performance period through May 19, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of any major subcontractors....
This federal contract award, with the ID SPE2DX15D2101|SPE2DX24F48LB, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,262.06 firm fixed-price delivery order is for the supply of Colestipol HCL 1 GM Tablets to support federal healthcare programs. The award has an ultimate completion date of November 20, 2023 and was made on November 17, 2023. This contract is not designated as a set-aside....
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Colestipol HCl 1 GM tablets. The contract is a Delivery Order valued at $7,352.07 with a firm fixed price, and has an ultimate completion date of July 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,220,957 units of Colestipol HCl 1 gram tablets. The $4,005.65 firm fixed price delivery order has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,557.54, is for the provision of Colestipol HCl 1 GM Tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This federal contract award is for the delivery of Colestipol HCL 1 GM Tablet in quantities of 120 tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $3,439.77 and is a firm fixed-price delivery order type. The contract has an ultimate completion date of November 17, 2023 and was awarded on November 16, 2023. There is no set-aside...
This federal contract award, valued at $1,753.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order and is for the supply of Colestipol HCL 1 GM Tablets in quantities of 120 tablets. The award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order (SPE2DX15D3001|SPE2DX24F4QW7) with a Firm Fixed Price pricing type, valued at $2,497.38, and has an ultimate completion date of January 19, 2024. The contract is for the supply of 4563358323 - COLESEVELAM 625 MG TABLET 180S, a medical product used for healthcare purposes. This award is not designated as a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FX3HM
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,558.53 placed by the Defense Logistics Agency (DLA) for the supply of COLESTID 1 GM TABLET 120S. The award has an ultimate completion date of October 10, 2023 and is a firm fixed-price contract.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is issued under that larger IDC contract. The contract does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 9:43 AM